Ultra-Fine III Mini Pen Needles - 31G 3/16" - BX 90 - Case of 5 (formerly BD)
$188.38 Original price was: $188.38.$77.61Current price is: $77.61.
BD Embecta Ultra-fine Short Pen Needles - 31G X 8mm (5/16") - Box of 100 (formerly BD)
$106.08 Original price was: $106.08.$43.70Current price is: $43.70.
BD Embecta Insulin Syringes Ultra Fine Needle – 30G 3/10cc 1/2″ – BX 100 (formerly BD)
$95.15 Original price was: $95.15.$39.20Current price is: $39.20.
19
Items sold in last 3 minutes
1000 in stock
🔥Buy 3, Get 1 Free – Mix & Match Any Products!🔥
Estimated delivery dates: Aug 6, 2026 - Aug 7, 2026
13
People watching this product now!
Description
Ultra Fine insulin syringes are designed for safety and comfort. They are engineered with optimal point geometry and are coated with special Micro Bonded lubrication for a smoother entry. All Embecta insulin syringes are manufactured with surgical grade steel and are guaranteed to be sterile.
Insulin Syringes Ultra Fine Needle Features:
- Engineered with optimal point geometry for maximum comfort and reliability.
- Coated with special Micro-Bonded lubrication for a more comfortable injection.
- Manufactured with a special surgical grade of stainless steel.
- Subject to 100% needle point inspection to assure consistent high quality.
- Non-toxic, Non-Pyrogenic and DO NOT Contain Latex.
Includes:
- 100 Embecta Ultra-Fine Needle Insulin Syringe 30 G x 3/10cc x 12.7 mm (1/2 in)
Notes:
- U-100 Insulin
- Sterility of fluid path guaranteed unless the insulin has been opened or damaged.
- This Product does NOT contain natural rubber latex.
- All Embecta Insulin Syringes are Non-Toxic and Non-Pyrogenic
- To ensure safety and comfort BD insulin syringes should only be used once.
Also in Quantities of:
BD Insulin Syringes Ultra Fine Needle -30G 3/10cc 1/2″ – Polybag of 10 Syringes
Additional information
| Weight | 0.34 lbs |
|---|
Reviews (0)
Be the first to review “BD Embecta Insulin Syringes Ultra Fine Needle – 30G 3/10cc 1/2″ – BX 100 (formerly BD)” Cancel reply

Reviews
There are no reviews yet.